76288-41-0Relevant articles and documents
TWO DIBENZOYLMETHANES FROM THE FROND EXUDATE OF NOTHOLAENA SPECIES
Roitman, James N.,Mann, Karin,Wollenweber, Eckhard
, p. 985 - 988 (1992)
Fronds of various ferns in the genus notholaena produce an exudate which consists mostly of flavonoid aglycones.In some species we found small amounts of two dibenzoylmethanes or β-diketones.These have been identified by spectroscopic methods.Both, 2',β,4-trihydroxy-4',6'-dimethoxychalcone and 2',β-dihydroxy-4',6',4-trimethoxychalcone, are novel natural products.The structures have been confirmed by synthesis of the latter compound. Key words: Notholaena; Pteridaceae; frond exudates; β-diketones; 2',β,4-trihydroxy-4',6'-dimethoxychalcone; 2',β-dihydroxy-4',6',4-trimethoxychalcone; 2',4'-dihydroxy-4',6'-dimethoxydibenzoylmethane, 2'-hydroxy-4',6',4-trimethoxydebenzoylmethane.
Synthesis and preliminary biological evaluation of chrysin derivatives as potential anticancer drugs
Zheng, Xing,Zhao, Fei Fei,Liu, Yun Mei,Yao, Xu,Zheng, Zi Tong,Luo, Xing,Liao, Duan Fang
scheme or table, p. 6 - 8 (2011/10/31)
A series of chrysin derivatives were prepared from 2-hydroxyacetophenone, 2,4-dihydroxyacetophenone, 2,4,6-trihydroxy- acetophenone, using modified Baker-Venkataraman transformation. Their anticancer activities in vitro were evaluated by the standard MTT method. The results of biological test showed that some of chrysin derivatives showed stronger anticancer activity than 5-fluorouracil.
Total synthesis of robustaflavone, a potential anti-hepatitis B agent
Zembower, David E.,Zhang, Heping
, p. 9300 - 9305 (2007/10/03)
Robustaflavone, a naturally occurring compound, is an inhibitor of hepatitis B virus replication in vitro. Robustaflavone is a biflavanoid composed of two units of apigenin (5,7,4'-trihydroxyflavone) joined via a biaryl linkage between the 6-position of one unit and the 3'-position of the other (I6,II3'-biapigenin). The natural material was isolated from the seed- kernels of Rhus succedanea. To provide ready access to sufficient quantities of material for continued biological studies, as well as to provide a general route for the preparation of structural analogues, a total synthesis of robustaflavone was pursued. The total synthesis was approached by constructing apigenin ethers containing functionalities at the 6- and 3'- positions which could be cross-coupled using transition metal catalysis. Key steps of the synthesis included development of a regioselective iodination of an apigenin derivative at the 6-position. Also key was the formation of an apigenin 3'-boronate using a palladium-catalyzed exchange of the corresponding 3'-iodide with a diboron reagent. Finally, identification of appropriate reaction conditions for Suzuki coupling to form the sterically congested 6-3''' biaryl bond of robustaflavone provided access to the desired biflavanoid system. This work represents the first total synthesis of robustaflavone.